Report Overview

Indian Anti-Acne Drugmarket size stood ataround USD XX billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of XX% during the forecast period.

Acne is a very common skin condition. It causes spots and painful bumps on the skin. It is most noticeable on the face, but can also appear on the back, shoulders, and buttocks. Severe acne can cause scarring. Acne usually starts in puberty, but it affects adults too. Acne will usually go away on its own, but it can take many years. Approximately 80% of people are affected by acne between the onset of puberty and 30 years of age. In 2019 in India about 12% of the respondents between 20 to 29 years of age had acne problems. Excess oil production, pores becoming clogged by sticky skin cells, bacteria and inflammation directly contributed to acne problems. By the end of 2028, the number of people affected by acne inIndiais estimated to reach 23 million at a compound annual growth rate (compound average growth rate) of 0.5%. Females are more prone to acne as compared to males inIndia. Growing internet penetration, an increasing number of e-commerce platforms selling these products, and increasing urbanization are estimated to improve the awareness among the target population, especially in developing economies. All these factors are projected to support the market growth.



Market Drivers

An increase in prevalence and severity of acne diseases is the major factor that contributes toward the growth of the acne medication market. Acne vulgaris is the most common skin problem amongst the teenaged population, with women being affected at higher rates than men. Moreover, other factors that fuel the market include an unhealthy urban lifestyle and the presence of robust acne medications in the pipeline. However, side-effects associated with the use of acne medications and the presence of alternative treatments impede the market growth. Conversely, the development of effective medications with lesser side effects and high market potential in untapped emerging economies is expected to provide lucrative growth opportunities for the market growth. Various factors such as fluctuating hormone levels, unhygienic lifestyle, and excessive production of oil from sebaceous glands have increased the prevalence of acne, thereby positively affecting the market growth.

Type of Acne Medication

Topical therapies dominated the market in 2017 by route of administration. Retinoids, antibiotics, BPO, salicylic acid, and azelaic acid are administered topically for mild-to-moderate acne as well as maintenance therapy. Oral medications are recommended as systemic therapies after topical treatments fail to evoke a response.